METSERA INC(NASDAQ:MTSR) stock News

MTSR Latest News, Press Relases and Analysis

All

Press Releases

2 days ago - By: Chartmill - Mentions: KOD QLGN CSAN AGRI ...

Top stock movements in today's session.

3 days ago - By: Chartmill - Mentions: XXII HSDT AGMH QLGN ...

Top movers analysis in the middle of the day on 2025-09-22: top gainers and losers in today's session.

a day ago - By: Halper Sadeh LLC - Mentions: ARIS GTLS MURA

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ARIS, MTSR, GTLS, MURA on Behalf of Shareholders

a day ago - By: Kahn Swick & Foti, LLC

METSERA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Metsera, Inc. - MTSR

2 days ago - By: Halper Sadeh LLC - Mentions: ARIS ODP SMLR

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ARIS, MTSR, ODP, SMLR on Behalf of Shareholders

2 days ago - By: The Motley Fool - Mentions: PFE LLY GS

What's Pfizer Getting in Its $7.3 Billion Metsera Buyout?

2 days ago - By: Stocktwits - Mentions: VKTX PFE ETNB

Viking Therapeutics Stock Gets Boost From Pfizer-Metsera Deal, Says BTIG — Retail Slams Rivals For Buying ‘Inferior Pipelines’

2 days ago - By: Stocktwits - Mentions: SPY QQQ DIA NVDA ...

Nvidia, Metsera, Oracle, Apple, Compass: Stocks Making The Biggest Moves Today

2 days ago - By: The Motley Fool - Mentions: PFE

Why Pfizer Stock Just Popped

2 days ago - By: Brodsky & Smith LLC - Mentions: PINC HOUS ODP PFE ...

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Premier, Inc. (Nasdaq – PINC), Metsera, Inc. (Nasdaq – MTSR), Anywhere Real Estate Inc. (NYSE – HOUS), The ODP Corporation (Nasdaq – ODP)

2 days ago - By: Benzinga - Mentions: CCCC MBX HSDT ADVM ...

12 Health Care Stocks Moving In Monday's Intraday Session

3 days ago - By: Benzinga - Mentions: PFE MBX QUBT QLGN ...

Gold Gains Over 1%; Quantum Computing Shares Plunge

3 days ago - By: Halper Sadeh LLP - Mentions: ODP

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ODP and MTSR on Behalf of Shareholders

3 days ago - By: Chartmill - Mentions: ODP PRO XXII AGMH ...

Let's uncover which stocks are experiencing notable gaps during today's session.

3 days ago - By: Ademi LLP

Shareholder Alert: The Ademi Firm investigates whether Metsera Inc. is obtaining a Fair Price for its Public Shareholders

3 days ago - By: Investor's Business Daily - Mentions: PFE

Pfizer Claws Deeper Into The Obesity Space With $4.9 Billion Metsera Deal

3 days ago - By: Chartmill - Mentions: ODP XXII AGMH BDSX ...

Monday's pre-market session: top gainers and losers

3 days ago - By: Halper Sadeh LLC

MTSR Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Metsera, Inc. Is Fair to Shareholders

3 days ago - By: Stocktwits - Mentions: PFE

Metsera Stock Surges 59% Pre-Market After Pfizer Confirms Acquisition – Here Are The Details

3 days ago - By: Pfizer Inc. - Mentions: PFE

Pfizer to Acquire Metsera and its Next-Generation Obesity Portfolio

3 days ago - By: Stocktwits - Mentions: PFE

Pfizer Stock Draws Focus On Report Of $7.3B Deal Plan For Metsera Buyout As Obesity Drug Race With Lilly, Novo Heats Up

3 days ago - By: Bloomberg - Mentions: PFE

Pfizer Nears Potential $7.3 Billion Takeover of Metsera, FT Says

14 days ago - By: Metsera, Inc.

Metsera to Present Research Highlighting its Next-Generation Obesity Portfolio at the 61st EASD Annual Meeting

14 days ago - By: Metsera, Inc.

Metsera to Present Research Highlighting its Next-Generation Obesity Portfolio at the 61st EASD Annual Meeting

a month ago - By: Metsera, Inc.

Metsera to Present at Upcoming September Investor Conferences

a month ago - By: Metsera, Inc.

Metsera to Present at Upcoming September Investor Conferences

2 months ago - By: Metsera, Inc.

Metsera Reports Second Quarter 2025 Financial Results and Continued Portfolio Progress

2 months ago - By: Metsera, Inc.

Metsera Reports Second Quarter 2025 Financial Results and Continued Portfolio Progress

2 months ago - By: Yahoo Finance - Mentions: JPM APGE

METSERA INC (MTSR) Stock News

MTSR Latest News, Press Relases and Analysis

Top stock movements in today's session.

Top movers analysis in the middle of the day on 2025-09-22: top gainers and losers in today's session.

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ARIS, MTSR, GTLS, MURA on Behalf of Shareholders

METSERA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Metsera, Inc. - MTSR

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ARIS, MTSR, ODP, SMLR on Behalf of Shareholders

What's Pfizer Getting in Its $7.3 Billion Metsera Buyout?

Viking Therapeutics Stock Gets Boost From Pfizer-Metsera Deal, Says BTIG — Retail Slams Rivals For Buying ‘Inferior Pipelines’

Nvidia, Metsera, Oracle, Apple, Compass: Stocks Making The Biggest Moves Today

Why Pfizer Stock Just Popped

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Premier, Inc. (Nasdaq – PINC), Metsera, Inc. (Nasdaq – MTSR), Anywhere Real Estate Inc. (NYSE – HOUS), The ODP Corporation (Nasdaq – ODP)

12 Health Care Stocks Moving In Monday's Intraday Session

Gold Gains Over 1%; Quantum Computing Shares Plunge

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ODP and MTSR on Behalf of Shareholders

Let's uncover which stocks are experiencing notable gaps during today's session.

Shareholder Alert: The Ademi Firm investigates whether Metsera Inc. is obtaining a Fair Price for its Public Shareholders

Pfizer Claws Deeper Into The Obesity Space With $4.9 Billion Metsera Deal

Monday's pre-market session: top gainers and losers

MTSR Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Metsera, Inc. Is Fair to Shareholders

Metsera Stock Surges 59% Pre-Market After Pfizer Confirms Acquisition – Here Are The Details

Pfizer to Acquire Metsera and its Next-Generation Obesity Portfolio

Pfizer Stock Draws Focus On Report Of $7.3B Deal Plan For Metsera Buyout As Obesity Drug Race With Lilly, Novo Heats Up

Pfizer Nears Potential $7.3 Billion Takeover of Metsera, FT Says

Metsera to Present Research Highlighting its Next-Generation Obesity Portfolio at the 61st EASD Annual Meeting

Metsera to Present Research Highlighting its Next-Generation Obesity Portfolio at the 61st EASD Annual Meeting

Metsera to Present at Upcoming September Investor Conferences

Metsera to Present at Upcoming September Investor Conferences

Metsera Reports Second Quarter 2025 Financial Results and Continued Portfolio Progress

Metsera Reports Second Quarter 2025 Financial Results and Continued Portfolio Progress

Metsera (MTSR) Presented at the 85th Scientific Sessions of the American Diabetes Association